Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
28 28 Search
2025
Hiperoxaluria secundaria: causas y consecuencias de la enfermedad renal crónica
Nefrología
2025
Involvement of Cholinergic and Cyclooxygenase Pathways in the Diuretic Effects of Rosmarinic Acid
Chemistry & Biodiversity
2025
Secondary hyperoxaluria: Cause and consequence of chronic kidney disease
Nefrología (English Edition)
2024
Profiling of Antidiabetic Bioactive Flavonoid Compounds from an Edible Plant Kudzu (Pueraria lobata)
Journal of Agricultural and Food Chemistry
2024
Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion
Hypertension Research
2023
Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin
PLOS ONE
2023
Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients
Metabolites
2023
Relationship between dapagliflozin and urinary albumin-to-creatinine ratio in patients with diabetes mellitus and cardiovascular disease: an observational study
Cardiology Plus
2023
Renal, cardiovascular, and safety outcomes of adding sodium–glucose cotransporter-2 inhibitors to insulin therapy in patients with type-2 diabetes: a meta-analysis
International Urology and Nephrology
2022
Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches
Journal of Cellular and Molecular Medicine
2022
Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation
Pharmacological Research
2022
Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials
Therapeutic Advances in Chronic Disease
2021
Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Hemoglobin Levels: A Meta-analysis of Randomized Controlled Trials
Frontiers in Pharmacology
2021
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
Medicine
2021
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews
Therapeutic Advances in Drug Safety
2021
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation
PLOS ONE
2020
Clinical Adverse Events of High-Dose vs Low-Dose Sodium–Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Meta-Analysis of 51 Randomized Clinical Trials
The Journal of Clinical Endocrinology & Metabolism
2020
Long‐term renal outcomes associated with sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
Diabetes/Metabolism Research and Reviews
2020
Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement
Diabetes Therapy
2019
Effect of SGLT2 inhibitor on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
International Urology and Nephrology
2019
Real-World Effectiveness of Sodium Glucose Co-Transporter-2 Inhibitors in Japanese Patients with Diabetes Mellitus
Diabetes Therapy
2019
Appraisal of Non-Cardiovascular Safety for Sodium–Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials
Frontiers in Pharmacology
2019
Risk assessment of urinary tract infections for patients receiving dapagliflozin
Journal of Intelligent & Fuzzy Systems
2019
Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
Frontiers in Endocrinology
2019
The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus
Journal of Hypertension
2018
SGLT2 inhibitors and the kidney: Effects and mechanisms
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
2018
The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Clinical Drug Investigation
2018
Effects of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trials
Diabetes, Obesity and Metabolism